Lawn, JE, Cousens, S, Darmstadt, GL, Paul, V, Martines, J. Why are 4 million newborn babies dying every year?
Lancet. 2004; 364, 2020.
Alonso-Spilsbury, M, Mota-Rojas, D, Villanueva-Garcia, D, et al. Perinatal asphyxia pathophysiology in pig and human: a review. Anim Reprod Sci. 2005; 90, 1–30.
Hankins, GD, Koen, S, Gei, AF, et al. Neonatal organ system injury in acute birth asphyxia sufficient to result in neonatal encephalopathy. Obstet Gynecol. 2002; 99(Pt 1), 688–691.
Shah, P, Riphagen, S, Beyene, J, Perlman, M. Multiorgan dysfunction in infants with post-asphyxial hypoxic-ischaemic encephalopathy. Arch Dis Child Fetal Neonatal Ed. 2004; 89, F152–F155.
Karlsson, M, Blennow, M, Nemeth, A, Winbladh, B. Dynamics of hepatic enzyme activity following birth asphyxia. Acta Paediatr. 2006; 95, 1405–1411.
Islam, MT, Islam, MN, Mollah, AH, et al. Status of liver enzymes in babies with perinatal asphyxia. Mymensingh Med J.
2011; 20, 446–449.
Okazaki, K, Nishida, A, Kato, M, et al. Elevation of cytokine concentrations in asphyxiated neonates. Biol Neonate. 2006; 89, 183–189.
Ashdown, H, Joita, S, Luheshi, GN, Boksa, P. Acute brain cytokine responses after global birth hypoxia in the rat. J Neurosci Res. 2008; 86, 3401–3409.
Mari, M, Fernandez-Checa, JC. Sphingolipid signalling and liver diseases. Liver Int. 2007; 27, 440–450.
Ding, WX, Yin, XM. Dissection of the multiple mechanisms of TNF-alpha-induced apoptosis in liver injury. J Cell Mol Med. 2004; 8, 445–454.
Vlassaks, E, Mencarelli, C, Nikiforou, M, et al. Fetal asphyxia induces acute and persisting changes in the ceramide metabolism in rat brain. J Lipid Res. 2013; 54, 1825–1833.
Zhai, ST, Liu, GY, Xue, F, et al. Changes of sphingolipids profiles after ischemia-reperfusion injury in the rat liver. Chin Med J. 2009; 122, 3025–3031.
Llacuna, L, Mari, M, Garcia-Ruiz, C, Fernandez-Checa, JC, Morales, A. Critical role of acidic sphingomyelinase in murine hepatic ischemia-reperfusion injury. Hepatology. 2006; 44, 561–572.
Vlassaks, E, Strackx, E, Vles, J, et al. Fetal asphyctic preconditioning modulates the acute cytokine response thereby protecting against perinatal asphyxia in neonatal rats. J Neuroinflammation. 2013; 10, 14.
Cai, Z, Sigrest, T, Hersey, K, Rhodes, PG. Intrauterine hypoxia-ischemia increases N-methyl-D-aspartate-induced cGMP formation and glutamate accumulation in cultured rat cerebellar granule cells. Pediatr Res. 1995; 38, 107–112.
Strackx, E, Van den Hove, DL, Prickaerts, J, et al. Fetal asphyctic preconditioning protects against perinatal asphyxia-induced behavioral consequences in adulthood. Behav Brain Res. 2010; 208, 343–351.
Strackx, E, Zoer, B, Van den Hove, D, et al. Brain apoptosis and carotid artery reactivity in fetal asphyctic preconditioning. Front Biosci (Schol Ed). 2010; 2, 781–790.
Kramer, BW, Moss, TJ, Willet, KE, et al. Dose and time response after intraamniotic endotoxin in preterm lambs. Am J Respir Crit Care Med. 2001; 164, 982–988.
Bieghs, V, Vlassaks, E, Custers, A, et al. Chorioamnionitis induced hepatic inflammation and disturbed lipid metabolism in fetal sheep. Pediatr Res. 2010; 68, 466–472.
Adibhatla, RM, Dempsy, R, Hatcher, JF. Integration of cytokine biology and lipid metabolism in stroke. Front Biosci. 2008; 13, 1250–1270.
Alessenko, AV, Galperin, EI, Dudnik, LB, et al. Role of tumor necrosis factor alpha and sphingomyelin cycle activation in the induction of apoptosis by ischemia/reperfusion of the liver. Biochemistry (Mosc). 2002; 67, 1347–1355.
Mencarelli, C, Martinez-Martinez, P. Ceramide function in the brain: when a slight tilt is enough. Cell Mol Life Sci. 2013; 70, 181–203.
Mencarelli, C, Bode, GH, Losen, M, et al. Goodpasture antigen-binding protein/ceramide transporter binds to human serum amyloid P-component and is present in brain amyloid plaques. J Biol Chem. 2012; 287, 14897–14911.
Mencarelli, C, Losen, M, Hammels, C, et al. The ceramide transporter and the goodpasture antigen binding protein: one protein – one function?
J Neurochem. 2010; 113, 1369–1386.
Al-Aubaidy, HA, Jelinek, HF. 8-Hydroxy-2-deoxy-guanosine identifies oxidative DNA damage in a rural prediabetes cohort. Redox Rep. 2010; 15, 155–160.
Marrazzo, G, Bosco, P, La Delia, F, et al. Neuroprotective effect of silibinin in diabetic mice. Neurosci Lett. 2011; 504, 252–256.
Maddaiah, VT. Glutathione correlates with lipid peroxidation in liver mitochondria of triiodothyronine-injected hypophysectomized rats. FASEB J. 1990; 4, 1513–1518.
Li Volti, G, Musumeci, T, Pignatello, R, et al. Antioxidant potential of different melatonin-loaded nanomedicines in an experimental model of sepsis. Exp Biol Med (Maywood). 2012; 237, 670–677.
Anthony, DC, Couch, Y, Losey, P, Evans, MC. The systemic response to brain injury and disease. Brain Behav Immun. 2012; 26, 534–540.
Martin-Ancel, A, Garcia-Alix, A, Pascual-Salcedo, D, et al. Interleukin-6 in the cerebrospinal fluid after perinatal asphyxia is related to early and late neurological manifestations. Pediatrics. 1997; 100, 789–794.
Silveira, RC, Procianoy, RS. Interleukin-6 and tumor necrosis factor-alpha levels in plasma and cerebrospinal fluid of term newborn infants with hypoxic-ischemic encephalopathy. J Pediatr. 2003; 143, 625–629.
Novgorodov, SA, Gudz, TI. Ceramide and mitochondria in ischemia/reperfusion. J Cardiovasc Pharmacol. 2009; 53, 198–208.
Jin, J, Hou, Q, Mullen, TD, et al. Ceramide generated by sphingomyelin hydrolysis and the salvage pathway is involved in hypoxia/reoxygenation-induced BAX redistribution to mitochondria in NT-2 cells. J Biol Chem. 2008; 283, 26509–26517.
Zhu, Q, Lin, L, Cheng, Q, et al. The role of acid sphingomyelinase and caspase 5 in hypoxia-induced HuR cleavage and subsequent apoptosis in hepatocytes. Biochim Biophys Acta. 2012; 1821, 1453–1461.
Dobrowsky, RT, Kolesnick, RN. Analysis of sphingomyelin and ceramide levels and the enzymes regulating their metabolism in response to cell stress. Methods Cell Biol. 2001; 66, 135–165.
Aly, H, Khashaba, MT, El-Ayouty, M, El-Sayed, O, Hasanein, BM. IL-1beta, IL-6 and TNF-alpha and outcomes of neonatal hypoxic ischemic encephalopathy. Brain Dev. 2006; 28, 178–182.
Gadient, RA, Otten, UH. Interleukin-6 (IL-6) – a molecule with both beneficial and destructive potentials. Prog Neurobiol. 1997; 52, 379–390.
Sharma, S, Yang, B, Xi, X, et al. IL-10 directly protects cortical neurons by activating PI-3 kinase and STAT-3 pathways. Brain Res. 2011; 1373, 189–194.
Park, KW, Lee, HG, Jin, BK, Lee, YB. Interleukin-10 endogenously expressed in microglia prevents lipopolysaccharide-induced neurodegeneration in the rat cerebral cortex in vivo. Exp Mol Med. 2007; 39, 812–819.
Suzuki, S, Tanaka, K, Suzuki, N. Ambivalent aspects of interleukin-6 in cerebral ischemia: inflammatory versus neurotrophic aspects. J Cereb Blood Flow Metab. 2009; 29, 464–479.
Sabat, R, Grutz, G, Warszawska, K, et al. Biology of interleukin-10. Cytokine Growth Factor Rev. 2010; 21, 331–344.
Maulik, N, Engelman, RM, Rousou, JA, et al. Ischemic preconditioning reduces apoptosis by upregulating anti-death gene Bcl-2. Circulation. 1999; 100(Suppl. 19), II369–II375.
Parsadanian, AS, Cheng, Y, Keller-Peck, CR, Holtzman, DM, Snider, WD. Bcl-XL is an antiapoptotic regulator for postnatal CNS neurons. J Neurosci. 1998; 18, 1009–1019.
Wiessner, C, Allegrini, PR, Rupalla, K, et al. Neuron-specific transgene expression of Bcl-XL but not Bcl-2 genes reduced lesion size after permanent middle cerebral artery occlusion in mice. Neurosci Lett. 1999; 268, 119–122.
Bonestroo, HJ, Nijboer, CH, van Velthoven, CT, et al. Cerebral and hepatic inflammatory response after neonatal hypoxia-ischemia in newborn rats. Dev Neurosci. 2013; 35, 197–211.
Chamorro, A, Urra, X, Planas, AM. Infection after acute ischemic stroke: a manifestation of brain-induced immunodepression. Stroke. 2007; 38, 1097–1103.
Grenz, A, Clambey, E, Eltzschig, HK. Hypoxia signaling during intestinal ischemia and inflammation. Curr Opin Crit Care. 2012; 18, 178–185.
Barker, DJ. The origins of the developmental origins theory. J Intern Med. 2007; 261, 412–417.
Vlassaks, E, Gavilanes, AWD, Bieghs, V, et al. Antenatal exposure to chorioamnionitis affects lipid metabolism in 7-week-old sheep. J Dev Orig Health Dis. 2012; 3, 103–110.
Rueda-Clausen, CF, Dolinsky, VW, Morton, JS, et al. Hypoxia-induced intrauterine growth restriction increases the susceptibility of rats to high-fat diet-induced metabolic syndrome. Diabetes. 2011; 60, 507–516.